Breaking News, Financial News

Financial Report: BASi

Revenues up 17% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

BASi   4Q Revenues: $6.4 million (+17%) 4Q Loss: $404,000 (earnings were $252,000 4Q13) YTD Revenues: $24.6 million (+11%) YTD Loss: $1.1 million (earnings were $773,000 YTD13) Comments: Service revenue for the quarter was up 23% to $4.9 million, due to an increase in Preclinical services studies offset slightly by lower Bioanalytical services revenue. Product revenue was flat at $1.5 million. Impairment charges of $374,000 impacted results in the quarter and FY....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters